Hanmi Science, the holding company of Hanmi Group, announced on May 21 that it has launched the dermacosmetic brand 'ADESII' as part of its strategy to penetrate the beauty market. As the dermatological science-based dermacosmetic sector becomes a key pillar of K-beauty, the company is well-positioned to enter the market, leveraging its existing pharmaceutical raw material technology and the trust associated with its pharmaceutical background.
ADESII is a premium dermacosmetic brand that emphasizes skin science and efficacy-driven design, built on Hanmi Group's pharmaceutical research and development capabilities. The brand highlights advanced technology, dermatological science, and efficacy clinical trials as its core concepts, focusing on ingredient formulations tailored to skin structure to demonstrate skin improvement effects. Notably, it emphasizes the ability to feel results within two weeks, which is half the skin turnover cycle.
The first product launched is the 'Black Pearl PDRN Neo Serum.' According to the company, this product has been shown to improve skin elasticity and density, and its safety has been confirmed through low-irritation testing.
The key ingredient is the patented 'H-EGTI,' a complex material that combines the natural amino acid 'EGT,' known for its antioxidant properties, with the plant-derived flavonoid 'Resistress.' This formulation is designed to maximize the skin's resistance to external stimuli and oxidative stress.
Following this launch, the company plans to sequentially expand its product line to include offerings for whitening, wrinkle reduction, and lifting.
A Hanmi Science representative stated, "We designed the formula based on pharmaceutical processes to ensure that consumers can directly experience skin changes. We aim to strengthen our brand presence in the dermacosmetic market."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.